156 related articles for article (PubMed ID: 38422475)
1. Comprehensive Inherited Risk Estimation for Risk-Based Breast Cancer Screening in Women.
Mars N; Kerminen S; Tamlander M; Pirinen M; Jakkula E; Aaltonen K; Meretoja T; Heinävaara S; Widén E; Ripatti S;
J Clin Oncol; 2024 May; 42(13):1477-1487. PubMed ID: 38422475
[TBL] [Abstract][Full Text] [Related]
2. Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes.
Gallagher S; Hughes E; Wagner S; Tshiaba P; Rosenthal E; Roa BB; Kurian AW; Domchek SM; Garber J; Lancaster J; Weitzel JN; Gutin A; Lanchbury JS; Robson M
JAMA Netw Open; 2020 Jul; 3(7):e208501. PubMed ID: 32609350
[TBL] [Abstract][Full Text] [Related]
3. Potential of polygenic risk scores for improving population estimates of women's breast cancer genetic risks.
Wolfson M; Gribble S; Pashayan N; Easton DF; Antoniou AC; Lee A; van Katwyk S; Simard J
Genet Med; 2021 Nov; 23(11):2114-2121. PubMed ID: 34230637
[TBL] [Abstract][Full Text] [Related]
4. Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score.
Gao C; Polley EC; Hart SN; Huang H; Hu C; Gnanaolivu R; Lilyquist J; Boddicker NJ; Na J; Ambrosone CB; Auer PL; Bernstein L; Burnside ES; Eliassen AH; Gaudet MM; Haiman C; Hunter DJ; Jacobs EJ; John EM; Lindström S; Ma H; Neuhausen SL; Newcomb PA; O'Brien KM; Olson JE; Ong IM; Patel AV; Palmer JR; Sandler DP; Tamimi R; Taylor JA; Teras LR; Trentham-Dietz A; Vachon CM; Weinberg CR; Yao S; Weitzel JN; Goldgar DE; Domchek SM; Nathanson KL; Couch FJ; Kraft P
J Clin Oncol; 2021 Aug; 39(23):2564-2573. PubMed ID: 34101481
[TBL] [Abstract][Full Text] [Related]
5. The impact of risk stratification by polygenic risk and age on breast cancer screening in women aged 40-49 years: a modelling study.
Huntley C; Torr B; Sud A; Houlston RS; Hingorani AD; Jones ME; Turnbull C
Lancet; 2023 Nov; 402 Suppl 1():S54. PubMed ID: 37997097
[TBL] [Abstract][Full Text] [Related]
6. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
Elife; 2023 Mar; 12():. PubMed ID: 36971353
[TBL] [Abstract][Full Text] [Related]
7. The role of polygenic risk and susceptibility genes in breast cancer over the course of life.
Mars N; Widén E; Kerminen S; Meretoja T; Pirinen M; Della Briotta Parolo P; Palta P; ; Palotie A; Kaprio J; Joensuu H; Daly M; Ripatti S
Nat Commun; 2020 Dec; 11(1):6383. PubMed ID: 33318493
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Breast Cancer Risk Assessment for
Gallagher S; Hughes E; Kurian AW; Domchek SM; Garber J; Probst B; Morris B; Tshiaba P; Meek S; Rosenthal E; Roa B; Slavin TP; Wagner S; Weitzel J; Gutin A; Lanchbury JS; Robson M
JCO Precis Oncol; 2021 Jun; 5():. PubMed ID: 34322652
[TBL] [Abstract][Full Text] [Related]
9. Utility of polygenic risk scores in UK cancer screening: a modelling analysis.
Huntley C; Torr B; Sud A; Rowlands CF; Way R; Snape K; Hanson H; Swanton C; Broggio J; Lucassen A; McCartney M; Houlston RS; Hingorani AD; Jones ME; Turnbull C
Lancet Oncol; 2023 Jun; 24(6):658-668. PubMed ID: 37178708
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of using artificial intelligence versus polygenic risk score to guide breast cancer screening.
Mital S; Nguyen HV
BMC Cancer; 2022 May; 22(1):501. PubMed ID: 35524200
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.
Kuchenbaecker KB; McGuffog L; Barrowdale D; Lee A; Soucy P; Dennis J; Domchek SM; Robson M; Spurdle AB; Ramus SJ; Mavaddat N; Terry MB; Neuhausen SL; Schmutzler RK; Simard J; Pharoah PDP; Offit K; Couch FJ; Chenevix-Trench G; Easton DF; Antoniou AC
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376175
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system.
Knerr S; Guo B; Wernli KJ; Mittendorf KF; Feigelson HS; Gilmore MJ; Jarvik GP; Kauffman TL; Keast E; Liles EG; Lynch FL; Muessig KR; Okuyama S; Veenstra DL; Zepp JM; Wilfond BS; Devine B; Goddard KAB
Breast Cancer Res Treat; 2023 Oct; 201(3):461-470. PubMed ID: 37470892
[TBL] [Abstract][Full Text] [Related]
14. The Burden of Breast Cancer Predisposition Variants Across The Age Spectrum Among 10 000 Patients.
Chavarri-Guerra Y; Hendricks CB; Brown S; Marcum C; Hander M; Segota ZE; Hake C; Sand S; Slavin TP; Hurria A; Soto-Perez-de-Celis E; Nehoray B; Blankstein KB; Blazer KR; Weitzel JN;
J Am Geriatr Soc; 2019 May; 67(5):884-888. PubMed ID: 31012959
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers.
Li J; Holm J; Bergh J; Eriksson M; Darabi H; Lindström LS; Törnberg S; Hall P; Czene K
Ann Oncol; 2015 Mar; 26(3):517-22. PubMed ID: 25488685
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab.
Li H; Feng B; Miron A; Chen X; Beesley J; Bimeh E; Barrowdale D; John EM; Daly MB; Andrulis IL; Buys SS; Kraft P; ; Thorne H; Chenevix-Trench G; Southey MC; Antoniou AC; James PA; Terry MB; Phillips KA; Hopper JL; Mitchell G; Goldgar DE
Genet Med; 2017 Jan; 19(1):30-35. PubMed ID: 27171545
[TBL] [Abstract][Full Text] [Related]
18. Overlap of high-risk individuals predicted by family history, and genetic and non-genetic breast cancer risk prediction models: implications for risk stratification.
Ho PJ; Ho WK; Khng AJ; Yeoh YS; Tan BK; Tan EY; Lim GH; Tan SM; Tan VKM; Yip CH; Mohd-Taib NA; Wong FY; Lim EH; Ngeow J; Chay WY; Leong LCH; Yong WS; Seah CM; Tang SW; Ng CWQ; Yan Z; Lee JA; Rahmat K; Islam T; Hassan T; Tai MC; Khor CC; Yuan JM; Koh WP; Sim X; Dunning AM; Bolla MK; Antoniou AC; Teo SH; Li J; Hartman M
BMC Med; 2022 Apr; 20(1):150. PubMed ID: 35468796
[TBL] [Abstract][Full Text] [Related]
19. Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis.
Lowry KP; Geuzinge HA; Stout NK; Alagoz O; Hampton J; Kerlikowske K; de Koning HJ; Miglioretti DL; van Ravesteyn NT; Schechter C; Sprague BL; Tosteson ANA; Trentham-Dietz A; Weaver D; Yaffe MJ; Yeh JM; Couch FJ; Hu C; Kraft P; Polley EC; Mandelblatt JS; Kurian AW; Robson ME;
JAMA Oncol; 2022 Apr; 8(4):587-596. PubMed ID: 35175286
[TBL] [Abstract][Full Text] [Related]
20. The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study.
Evans DG; Brentnall A; Byers H; Harkness E; Stavrinos P; Howell A; ; Newman WG; Cuzick J
J Med Genet; 2017 Feb; 54(2):111-113. PubMed ID: 27794048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]